A possible blood plasma biomarker for early-stage Alzheimer’s disease

We sought to identify a usable biomarker from blood samples to characterize early-stage Alzheimer’s disease (AD) patients, in order to facilitate rapid diagnosis, early therapeutic intervention, and monitoring of clinical trials. We compared metabolites from blood plasma in early-stage Alzheimer’s d...

Descripción completa

Detalles Bibliográficos
Autores principales: Banack, Sandra Anne, Stark, Aleksandra C., Cox, Paul Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022864/
https://www.ncbi.nlm.nih.gov/pubmed/35446894
http://dx.doi.org/10.1371/journal.pone.0267407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022864/
https://www.ncbi.nlm.nih.gov/pubmed/35446894
http://dx.doi.org/10.1371/journal.pone.0267407

Ejemplares similares